// App-Quantinova.ai

P2-02-12 : Association of inflammatory and tumor markers with circulating tumor cells in metastatic breast cancer

Researchers

Presenter

  • Lohmann AE

Principal Investigators

  • Chang M

  • Dowling RJO

  • Goodwin PJ

  • Ennis M

  • Amir E

  • Elser C

  • Brezden-Masley C

  • Vandenberg T

  • Lee E

  • Fazae K

  • Stambolic V

Medical Centers

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • University of Toronto, Toronto, ON, Canada

  • London Regional Cancer Centre, London, ON, Canada

  • Applied Statistician, Markham, ON, Canada

  • St. Michael's Hosp, Toronto, ON, Canada

  • Mount Sinai Hospital, Toronto, ON, Canada

  • The Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Diabetes

  • Solid malignancies

Biomarkers

  • C reactive protein

  • Plasminogen activator ihnibitor-1

  • Circulating tumor cells

  • Interleukin 6

  • Vascular endothelial growth factor A

Drug/Treatment

  • CA15-3

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim